Repository logo
 
Publication

Effects and Mechanisms of Action of Preussin, a Marine Fungal Metabolite, against the Triple-Negative Breast Cancer Cell Line, MDA-MB-231, in 2D and 3D Cultures

dc.contributor.authorSeabra, Rosária
dc.contributor.authorMalhão, Fernanda
dc.contributor.authorCorreia, Alexandra
dc.contributor.authorCosta, Carla
dc.contributor.authorKijjoa, Anake
dc.contributor.authorRocha, Eduardo
dc.date.accessioned2024-02-08T15:37:03Z
dc.date.available2024-02-08T15:37:03Z
dc.date.issued2023-03
dc.description.abstractTriple-negative breast cancer (TNBC) represents an aggressive subtype of breast cancer (BC) with a typically poorer prognosis than other subtypes of BC and limited therapeutic options. Therefore, new drugs would be particularly welcome to help treat TNBC. Preussin, isolated from the marine sponge-associated fungus, Aspergillus candidus, has shown the potential to reduce cell viability and proliferation as well as to induce cell death and cell cycle arrest in 2D cell culture models. However, studies that better mimic the tumors in vivo, such as 3D cell cultures, are needed. Here, we studied the effects of preussin in the MDA-MB-231 cell line, comparing 2D and 3D cell cultures, using ultrastructural analysis and the MTT, BrdU, annexin V-PI, comet (alkaline and FPG modified versions), and wound healing assays. Preussin was found to decrease cell viability, both in 2D and 3D cell cultures, in a dose-dependent manner, impair cell proliferation, and induce cell death, therefore excluding the hypothesis of genotoxic properties. The cellular impacts were reflected by ultrastructural alterations in both cell culture models. Preussin also significantly inhibited the migration of MDA-MB-231 cells. The new data expanded the knowledge on preussin actions while supporting other studies, highlighting its potential as a molecule or scaffold for the development of new anticancer drugs against TNBC.pt_PT
dc.description.sponsorshipThis research was partially supported by the strategic funding UIDB/04423/2020 and UIDP/04423/2020 through national funds provided by FCT—Fundação para a Ciência e a Tecnologia to CIIMAR. The Master in Oncology of the ICBAS—U.Porto offered additional support.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationMar Drugs. 2023 Mar 4;21(3):166. doi: 10.3390/md21030166.pt_PT
dc.identifier.doi10.3390/md21030166pt_PT
dc.identifier.issn1660-3397
dc.identifier.urihttp://hdl.handle.net/10400.18/9057
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherMDPIpt_PT
dc.relationInterdisciplinary Centre of Marine and Environmental Research
dc.relationInterdisciplinary Centre of Marine and Environmental Research
dc.relation.publisherversionhttps://www.mdpi.com/1660-3397/21/3/166pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subject3D Cell Culturept_PT
dc.subjectCancer Cells Deathpt_PT
dc.subjectCytotoxicity; Preussinpt_PT
dc.subjectTriple-negative Breast Cancerpt_PT
dc.subjectToxicologiapt_PT
dc.titleEffects and Mechanisms of Action of Preussin, a Marine Fungal Metabolite, against the Triple-Negative Breast Cancer Cell Line, MDA-MB-231, in 2D and 3D Culturespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleInterdisciplinary Centre of Marine and Environmental Research
oaire.awardTitleInterdisciplinary Centre of Marine and Environmental Research
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04423%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04423%2F2020/PT
oaire.citation.issue3pt_PT
oaire.citation.startPage166pt_PT
oaire.citation.titleMarine Drugspt_PT
oaire.citation.volume21pt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.embargofctAcesso de acordo com política editorial da revista.pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublicatione47e16ab-4259-4ce8-af09-551f7f31443a
relation.isProjectOfPublicationc3064e67-096b-442c-b636-ae0e2da784a3
relation.isProjectOfPublication.latestForDiscoverye47e16ab-4259-4ce8-af09-551f7f31443a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
marinedrugs-21-00166-v2.pdf
Size:
57.32 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: